Olof Beck Selected Research

Amphetamine-Related Disorders (Addiction, Amphetamine)

3/2014	Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial.
4/2010	Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
11/2008	Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.
7/2008	Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
1/2005	An open clinical trial of naltrexone for amphetamine dependence: compliance and tolerability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olof Beck Research Topics

Disease

6	Substance-Related Disorders (Drug Abuse) 01/2019 - 04/2010
5	Alcoholism (Alcohol Abuse) 12/2015 - 05/2004
5	Amphetamine-Related Disorders (Addiction, Amphetamine) 03/2014 - 01/2005
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2019 - 04/2010
4	Poisoning 01/2017 - 11/2015
3	Epilepsy (Aura) 05/2017 - 06/2008
2	COVID-19 01/2022 - 10/2021
2	Pain (Aches) 10/2021 - 12/2014
2	Malaria 05/2017 - 03/2009
2	Falciparum Malaria (Plasmodium falciparum Malaria) 05/2017 - 03/2009
2	Tachycardia (Tachyarrhythmias) 11/2015 - 11/2015
2	Isolated Systolic Hypertension 11/2015 - 11/2015
2	Stroke (Strokes) 10/2014 - 09/2003
2	Atrial Fibrillation 10/2014 - 11/2013
2	Body Weight (Weight, Body) 10/2014 - 09/2003
1	Infections 01/2022
1	Cough 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Human Influenza (Influenza) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	ST Elevation Myocardial Infarction 01/2019
1	Mental Disorders (Mental Disorder) 01/2018
1	Cerebral Hemorrhage 01/2016
1	Confusion (Bewilderment) 11/2015
1	Hyperthermia 11/2015
1	Hallucinations (Hallucination) 11/2015
1	Narcolepsy 08/2015
1	Apnea 01/2015
1	Respiratory Insufficiency (Respiratory Failure) 01/2015
1	Neoplasms (Cancer) 12/2014
1	Hemorrhage 10/2014
1	Mastocytoma 08/2012
1	Urticaria Pigmentosa 08/2012
1	Mastocytosis 08/2012
1	Obesity 01/2009
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 05/2007

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 01/2018 - 07/2008
6	Amphetamine (Amfetamine)FDA LinkGeneric 11/2019 - 07/2008
3	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 04/2003
3	Narcotics (Narcotic Analgesics)IBA 08/2016 - 11/2010
3	Methylphenidate (Ritalin)FDA LinkGeneric 08/2014 - 04/2010
3	Acamprosate (Campral)FDA Link 08/2010 - 05/2004
3	Naltrexone (ReVia)FDA LinkGeneric 11/2008 - 01/2005
2	Methadone (Dolophine)FDA LinkGeneric 10/2021 - 01/2019
2	Buprenorphine (Subutex)FDA LinkGeneric 10/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2021
2	Anticonvulsants (Antiepileptic Drugs)IBA 05/2017 - 01/2015
2	Lamotrigine (Lamictal)FDA LinkGeneric 05/2017 - 06/2008
2	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 05/2017 - 03/2009
2	Heroin (Diamorphine)IBA 12/2014 - 04/2003
2	Dabigatran FDA Link 10/2014 - 11/2013
2	CreatinineIBA 10/2014 - 09/2003
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 08/2014 - 09/2003
1	Dronabinol (THC)FDA LinkGeneric 01/2022
1	AerosolsIBA 01/2022
1	CannabidiolIBA 01/2022
1	CannabinoidsIBA 01/2022
1	VaccinesIBA 10/2021
1	Hydromorphone (Dilaudid)FDA LinkGeneric 10/2021
1	hypoxanthine arabinoside (ara-H)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	AllergensIBA 01/2021
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2019
1	TicagrelorIBA 01/2019
1	methylnaltrexone FDA Link 01/2019
1	AmphetaminesIBA 01/2019
1	BenzodiazepinesIBA 01/2019
1	Fentanyl (Sublimaze)FDA LinkGeneric 03/2018
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2017
1	TabletsIBA 05/2017
1	Carbamazepine (Tegretol)FDA LinkGeneric 05/2017
1	Lumefantrine FDA Link 05/2017
1	PoisonsIBA 01/2017
1	methyl 2- (1- (cyclohexylmethyl)- 1H- indole- 3- carboxamido)- 3,3- dimethylbutanoateIBA 01/2017
1	N- (1- phenethylpiperidin- 4- yl)- N- phenylacetamideIBA 01/2016
1	Dopamine (Intropin)FDA LinkGeneric 12/2015
1	OSU 6162IBA 12/2015
1	Synthetic CathinoneIBA 11/2015
1	methoxydineIBA 11/2015
1	Opioid Analgesics (Opioids)IBA 01/2015
1	morphine-6-glucuronideIBA 12/2014
1	AntithrombinsIBA 10/2014
1	Serotonin (5 Hydroxytryptamine)IBA 08/2012
1	5-HT1 Serotonin ReceptorsIBA 08/2012
1	5-HT1A Serotonin ReceptorIBA 08/2012
1	Biomarkers (Surrogate Marker)IBA 02/2012
1	Central Nervous System StimulantsIBA 04/2010
1	Cocaine (Cocaine HCl)IBA 04/2010
1	Therapeutic UsesIBA 07/2009
1	ArtesunateIBA 03/2009
1	artemisinin (artemisinine)IBA 03/2009
1	Amodiaquine (Camoquin)FDA Link 03/2009
1	DeuteriumIBA 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 01/2009

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2015 - 01/2005
1	Critical Care (Surgical Intensive Care) 01/2016
1	Therapeutics 03/2009
1	Liver Transplantation 05/2007